| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.098 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |